Researchers use snRNA-seq to identify malignant cells responsible for relapse in neuroblastoma

Study is the first to identify malignant cells responsible for relapse in high-risk neuroblastoma Researchers at Children’s Hospital of Philadelphia (CHOP) announced a significant breakthrough in understanding chemotherapy resistance in high-risk neuroblastoma, a common and potentially deadly childhood cancer arising within the peripheral nervous system. The study marks the first time that researchers identified …